🇺🇸 Leukoreduced blood components in United States

Leukoreduced blood components (Leukoreduced blood components) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Leukoreduced blood components in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Leukoreduced blood components approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Leukoreduced blood components in United States?

University of Washington is the originator. The local marketing authorisation holder may differ — check the official source linked above.